Safety of DOACs in patients with Child-Pugh Class C cirrhosis and trial fibrillation.

Mark AyoubCarol FarisJulton Tomanguillo ChumbeEbubekir DaglilarNadeem AnwarVishnu Naravadi

Published in: JGH open : an open access journal of gastroenterology and hepatology (2024)

Anticoagulation is safe in patients with CPC with AF and may provide a mortality benefit. DOACs are a safer alternative to warfarin.

Keyphrases